Evidence map›Paper›PMID 26974332›Full record

Trial reportPloS one2016

Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.

Heleen Demeyer, Elena Gimeno-Santos, Roberto A Rabinovich, Miek Hornikx, Zafeiris Louvaris, Willem I de Boer, Niklas Karlsson, Corina de Jong, Thys Van der Molen, Ioannis Vogiatzis and 5 more

2 registry-linked trialsAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01388218 completednot on this map

Non-interventional Cross-over Study to Reduce Items of the Draft PROactive Tools as a Measure of Physical Activity in Daily Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

TypeobservationalSponsorBarcelona Institute for Global HealthRan2011 to 2012Enrolled236ConditionsChronic Obstructive Pulmonary Disease (COPD)
NCT03050424 phase2unknown statusnot on this mapstarted 2017, after this paper: background citation

Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial

TypeinterventionalSponsorRoyal Brompton & Harefield NHS Foundation TrustRan2017 to 2019Enrolled40ConditionsChronic Obstructive Pulmonary DiseaseArmsFerric Carboxymaltose, Sodium Chloride 0.9%
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Heleen DemeyerKU Leuven, Department of Rehabilitation Sciences, B-3000, Leuven, Belgium.
Elena Gimeno-SantosCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Roberto A RabinovichELEGI/Colt laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, Scotland.
Miek HornikxKU Leuven, Department of Rehabilitation Sciences, B-3000, Leuven, Belgium.
Zafeiris LouvarisDept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece.
Willem I de BoerDepartment of Pulmonology, Leiden University Medical Center, Leiden, Netherlands.
Niklas KarlssonAstra Zeneca, Mölndal, Sweden.
Corina de JongDepartment of General Practice, University Medical Center Groningen, Groningen, Netherlands.
Thys Van der MolenDepartment of Primary Care, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
Ioannis VogiatzisDept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece.
Wim JanssensUniversity Hospitals Leuven, Department of Respiratory Diseases, B-3000, Leuven, Belgium.
Judith Garcia-AymerichCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Thierry TroostersKU Leuven, Department of Rehabilitation Sciences, B-3000, Leuven, Belgium.
Michael I PolkeyNIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS foundation Trust and Imperial College London, London, United Kingdom.
PROactive consortium

Funding

Medical Research Council G0901697
6 · The paper itself

Abstract

backgroundThe GOLD multidimensional classification of COPD severity combines the exacerbation risk with the symptom experience, for which 3 different questionnaires are permitted. This study investigated differences in physical activity (PA) in the different GOLD quadrants and patient's distribution in relation to the questionnaire used.

methods136 COPD patients (58±21% FEV1 predicted, 34F/102M) completed COPD assessment test (CAT), clinical COPD questionnaire (CCQ) and modified Medical Research Council (mMRC) questionnaire. Exacerbation history, spirometry and 6MWD were collected. PA was objectively measured for 2 periods of 1 week, 6 months apart, in 5 European centres; to minimise seasonal and clinical variation the average of these two periods was used for analysis.

resultsGOLD quadrants C+D had reduced PA compared with A+B (3824 [2976] vs. 5508 [4671] steps.d-1, p<0.0001). The choice of questionnaire yielded different patient distributions (agreement mMRC-CAT κ = 0.57; CCQ-mMRC κ = 0.71; CCQ-CAT κ = 0.72) with different clinical characteristics. PA was notably lower in patients with an mMRC score ≥2 (3430 [2537] vs. 5443 [3776] steps.d-1, p <0.001) in both the low and high risk quadrants.

conclusionsUsing different questionnaires changes the patient distribution and results in different clinical characteristics. Therefore, standardization of the questionnaire used for classification is critical to allow comparison of different studies using this as an entry criterion. CLINICAL

trial registrationClinicalTrials.gov NCT01388218.

Indexed as

Motor ActivitySurveys and QuestionnairesAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPulmonary Disease, Chronic Obstructive

Identifiers

PMID26974332
PMCPMC4790973

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.